UPSC Editorial Analysis: Draft WHO Pandemic Treaty (2024)
Kartavya Desk Staff
*General Studies-2; Topic: Important International institutions, agencies and fora- their structure, mandate.*
Introduction
• The Covid-19 pandemic exposed deep fault lines in global health governance, particularly in areas such as information transparency, vaccine nationalism, and inequitable distribution of critical health supplies.
• In March 2021, over 20 countries and international organizations proposed a global treaty to better prepare for future pandemics.
• An Intergovernmental Negotiating Body (INB) was established in December 2021 by WHO member states to draft this international health instrument.
Key Features of the Draft WHO Pandemic Treaty
• One Health Approach: Recognizes the interconnectedness of human, animal, and environmental health. Mandates surveillance of zoonotic spillovers and encourages mitigation strategies to prevent cross-species pathogen transmission.
• Recognizes the interconnectedness of human, animal, and environmental health.
• Mandates surveillance of zoonotic spillovers and encourages mitigation strategies to prevent cross-species pathogen transmission.
• Pathogen and Data Sharing: Encourages countries to rapidly share pathogen samples and genetic sequencing data. Nations sharing such data will get preferential access to the diagnostics and vaccines developed from this information.
• Encourages countries to rapidly share pathogen samples and genetic sequencing data.
• Nations sharing such data will get preferential access to the diagnostics and vaccines developed from this information.
• Equity in Access: Aims to correct past inequities in vaccine and therapeutic distribution by linking information sharing with fair benefit-sharing mechanisms. Responds to Global South concerns, particularly low- and middle-income countries (LMICs), about being left behind in past health emergencies.
• Aims to correct past inequities in vaccine and therapeutic distribution by linking information sharing with fair benefit-sharing mechanisms.
• Responds to Global South concerns, particularly low- and middle-income countries (LMICs), about being left behind in past health emergencies.
• Public Interest over Intellectual Property: Advances the notion that public-funded research should lead to equitable access. Attempts to reform IPR regimes that hindered global health responses during Covid-19.
• Advances the notion that public-funded research should lead to equitable access.
• Attempts to reform IPR regimes that hindered global health responses during Covid-19.
• Limitations: Lacks a robust enforcement mechanism, making compliance voluntary. The final draft excludes the US, although it participated in early negotiations. The scope is narrower than initially envisioned in 2021.
• Lacks a robust enforcement mechanism, making compliance voluntary.
• The final draft excludes the US, although it participated in early negotiations.
• The scope is narrower than initially envisioned in 2021.
Geopolitical and Strategic Implications
• Multilateralism Revived: With ratification by 191 countries, the treaty showcases renewed faith in WHO-led global governance despite initial US disengagement.
• With ratification by 191 countries, the treaty showcases renewed faith in WHO-led global governance despite initial US disengagement.
• North-South Divide: Highlights the conflicting priorities of developed nations (scientific access) vs. developing ones (equity and access). The compromise indicates growing bargaining power of the Global South in multilateral negotiations.
• Highlights the conflicting priorities of developed nations (scientific access) vs. developing ones (equity and access).
• The compromise indicates growing bargaining power of the Global South in multilateral negotiations.
Scientific and Public Health Implications
• Creates frameworks for timely detection and prevention of emerging diseases.
• Institutionalizes collaborative research and global disease surveillance networks.
• Reinforces early warning systems through cross-border sharing of pathogen data.
Legal and Policy Dimensions
• Establishes non-binding international norms on pandemic preparedness.
• Sets the groundwork for future legal instruments on global public goods in healthcare.
• Reflects principles of equity, solidarity, and accountability in global health law.
Challenges Ahead
• Implementation gap due to absence of penalties for non-compliance.
• Potential pushback from pharmaceutical companies and IPR lobbies.
• Domestic ratification hurdles, especially in countries where global treaties are subject to legislative approval (e.g., USA).
Way Forward
• Introduce accountability frameworks with periodic reviews, peer assessments, and public reporting.
• Operationalize a Global Pandemic Equity Fund, funded by developed nations, pharma taxes, or sovereign contributions.
• Encourage regional pharma manufacturing hubs in the Global South to reduce dependency.
• Encourage community-level participation and awareness about zoonotic disease risks.
• Actively engage the United States and major non-aligned powers to ensure universal ratification and implementation.
• Leverage forums like G20, G7, BRICS, and Global South Summits to create political momentum.
• Strengthen the WHO Contingency Fund for Emergencies (CFE) to support treaty implementation.
Conclusion
• WHO Pandemic Treaty 2024 marks a historic first step toward a binding global framework for pandemic preparedness and response.
• The treaty’s emphasis on One Health, equitable access, and data sharing reflects lessons from Covid-19 and sets the stage for a more resilient and cooperative global health architecture.
• Its success, however, will depend on political will, global solidarity, and future amendments to strengthen enforcement and compliance.
Discuss the importance of the One Health approach in the context of future pandemic preparedness. (250 Words)